RxDoctor Payments DataLook up a doctor →

Rex Heaton, NP

Family · Saint George, UTNPI 1477627917

Payments from drug & device makers

$15,891in general payments, 2019–2025

Across 806 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Merck$1K
  • Johnson & Johnson$963
  • Pfizer$824
  • Astellas Pharma US Inc$728
  • Seagen Inc.$674
  • plus $10K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)76$1,653
Merck48$1,037
Johnson & Johnson(2 entities)51$963
Pfizer61$824
Astellas Pharma US Inc22$728
Seagen Inc.40$674
Sanofi22$599
Daiichi Sankyo Inc.32$594
Novartis23$518
E.r. Squibb & Sons, L.L.C.29$517
Eisai Inc.28$489
Genentech USA, Inc.21$481
Lilly USA, LLC25$446
Amgen29$432
Incyte Corporation23$424
AbbVie19$375
Pharmacyclics LLC, An Abbvie Company16$353
Dendreon Pharmaceuticals LLC11$344
Bristol Myers Squibb22$339
GSK16$335
Gilead(2 entities)14$287
EMD Serono, Inc.14$262
Bayer14$251
Boehringer Ingelheim10$226
Regeneron Healthcare Solutions, Inc.8$167
Myovant Sciences Inc.11$165
Sobi, Inc7$158
Array Biopharma Inc10$133
Takeda Pharmaceuticals U.S.A., Inc.5$132
Sumitomo Pharma America, Inc.6$131
Coherus Oncology, Inc.6$116
Genmab U.S., Inc.5$115
Beigene USA, Inc.5$111
Karyopharm Therapeutics Inc.5$102
Blueprint Medicines Corporation4$97
Jazz Pharmaceuticals Inc.6$95
Stemline Therapeutics Inc.5$94
AVEO Pharmaceuticals, Inc.2$89
Rigel Pharmaceuticals, Inc.4$68
Servier Pharmaceuticals LLC3$65
Geron Corporation3$64
Puma Biotechnology, Inc.3$57
Deciphera Pharmaceuticals Inc.3$56
Pharmaessentia USA Corporation3$55
Tersera Therapeutics LLC2$44
CTI Biopharma Corp.2$43
G1 Therapeutics, Inc.2$40
Celltrion USA Inc.1$37
Ipsen Biopharmaceuticals, Inc2$36
Agios Pharmaceuticals, Inc.2$35
CSL Behring2$34
Heron Therapeutics, Inc.2$33
Tolmar Pharmaceuticals, Inc.2$32
Recordati_rare_diseases_inc.1$31
Exelixis Inc.2$30
Acrotech Biopharma Inc.2$30
Morphosys, US Inc.2$28
Amneal Pharmaceuticals LLC1$25
Fennec Pharmaceuticals, Inc.1$23
Epizyme, Inc.1$22

How this compares

$15,891 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.

See all family providers in Utah →

Medicare billing

Part B allowed, 2024
$783,726
Medicare patients
253
Services billed
42,218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Saint George

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →